Delcath Systems, Inc.

DCTHNASDAQHealthcare● Active

$10.94

+$0.27(+2.53%)

Market Cap$377666818

P/E Ratio—

52W High$16.68

52W Low$8.12

Avg Volume380K

Open$10.78

Beta0.52

Insider Trades Ownership Employees

Delcath Systems, Inc.（DCTH）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · DCTH · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

∞

Buy/Sell (by trades)

整体情绪

偏多

↑ Buy 100%仅显示有效交易 · 排除RSU归属0% Sell ↓

Delcath Systems, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

DCTH 季度内部人买卖趋势

DCTH 内幕交易卖出 · DCTH 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

6.9M3.4M0

2024 Q1

2024 Q2

2024 Q4

2025 Q1

2025 Q2

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

活跃内部人

近12个月交易最活跃 · DCTH CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

DCTH 高管卖出股份 · DCTH 董事内幕交易 · SEC Form 4申报

显示最近 13 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Mar 6, 2026	Pennell Sandra CFO	Purchase	5,533	$9.04	$50K	77,018	Form 4
Mar 2, 2026	MICHEL GERARD J CHIEF EXECUTIVE OFFICER · Director	Purchase	11,200	$8.96	$100K	342,034	Form 4
Nov 21, 2025	Sylvester John Richard Director	Purchase	4,386	$8.89	$39K	14,936	Form 4
Nov 11, 2025	MICHEL GERARD J CHIEF EXECUTIVE OFFICER · Director	Purchase	11,500	$8.53	$98K	330,834	Form 4
Jun 12, 2025	Vukovic Vojo CHIEF MEDICAL OFFICER	Option	42,000	$4.78	$201K	168,882	Form 4
Oct 22, 2024	MICHEL GERARD J CHIEF EXECUTIVE OFFICER · Director	Option	16,666	$6.00	$100K	319,334	Form 4
Mar 19, 2024	Vukovic Vojo CHIEF MEDICAL OFFICER	Award	26,882	$3.72	$100K	126,882	Form 4
Mar 19, 2024	MICHEL GERARD J CHIEF EXECUTIVE OFFICER · Director	Award	40,323	$3.72	$150K	302,668	Form 4
Mar 19, 2024	Pennell Sandra SVP OF FINANCE, PFO AND PAO	Award	26,881	$3.72	$100K	61,052	Form 4
Mar 19, 2024	Muir Kevin GM INTERVENTIONAL ONCOLOGY	Award	13,441	$3.72	$50K	18,582	Form 4
Mar 19, 2024	Hoffman David L. GEN'L COUNSEL, CCO & SECY	Award	20,161	$3.72	$75K	74,330	Form 4
Dec 12, 2023	Vukovic Vojo Chief Medical Officer	Purchase	40,000	$3.00	$120K	100,000	Form 4
Dec 8, 2023	MICHEL GERARD J CEO · Director	Purchase	34,000	$2.94	$100K	262,345	Form 4

Pennell Sandra

CFO

Purchase

日期

Mar 6

股数

5,533

均价

$9.04

总金额

$50K

View Form 4 on SEC.gov

MICHEL GERARD J

CHIEF EXECUTIVE OFFICER · Director

Purchase

日期

Mar 2

股数

11,200

均价

$8.96

总金额

$100K

View Form 4 on SEC.gov

Sylvester John Richard

Director

Purchase

日期

Nov 21

股数

4,386

均价

$8.89

总金额

$39K

View Form 4 on SEC.gov

MICHEL GERARD J

CHIEF EXECUTIVE OFFICER · Director

Purchase

日期

Nov 11

股数

11,500

均价

$8.53

总金额

$98K

View Form 4 on SEC.gov

Vukovic Vojo

CHIEF MEDICAL OFFICER

Option

日期

Jun 12

股数

42,000

均价

$4.78

总金额

$201K

View Form 4 on SEC.gov

MICHEL GERARD J

CHIEF EXECUTIVE OFFICER · Director

Option

日期

Oct 22

股数

16,666

均价

$6.00

总金额

$100K

View Form 4 on SEC.gov

Vukovic Vojo

CHIEF MEDICAL OFFICER

Award

日期

Mar 19

股数

26,882

均价

$3.72

总金额

$100K

View Form 4 on SEC.gov

MICHEL GERARD J

CHIEF EXECUTIVE OFFICER · Director

Award

日期

Mar 19

股数

40,323

均价

$3.72

总金额

$150K

View Form 4 on SEC.gov

Pennell Sandra

SVP OF FINANCE, PFO AND PAO

Award

日期

Mar 19

股数

26,881

均价

$3.72

总金额

$100K

View Form 4 on SEC.gov

Muir Kevin

GM INTERVENTIONAL ONCOLOGY

Award

日期

Mar 19

股数

13,441

均价

$3.72

总金额

$50K

View Form 4 on SEC.gov

Hoffman David L.

GEN'L COUNSEL, CCO & SECY

Award

日期

Mar 19

股数

20,161

均价

$3.72

总金额

$75K

View Form 4 on SEC.gov

Vukovic Vojo

Chief Medical Officer

Purchase

日期

Dec 12

股数

40,000

均价

$3.00

总金额

$120K

View Form 4 on SEC.gov

MICHEL GERARD J

CEO · Director

Purchase

日期

Dec 8

股数

34,000

均价

$2.94

总金额

$100K

View Form 4 on SEC.gov

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 DCTH 内幕交易

DCTH 内幕交易

Delcath Systems, Inc.（DCTH）内幕交易数据来源于公司内部人（包括MICHEL GERARD J (CHIEF EXECUTIVE OFFICER · Director), Pennell Sandra (CFO), Sylvester John Richard (Director)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。DCTH内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Delcath Systems, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

DCTH 内幕交易 · 5个问题

Delcath Systems, Inc.（DCTH）的内部人包括高管和董事，如MICHEL GERARD J (CHIEF EXECUTIVE OFFICER · Director), Pennell Sandra (CFO), Sylvester John Richard (Director)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

DCTH 董事内幕交易DCTH 内部人名单Delcath Systems, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026